国际眼科纵览 ›› 2015, Vol. 39 ›› Issue (1): 55-60.doi: 103706/ cma.j.issn.1673\|5803201501011

• 综述 • 上一篇    下一篇

活动期甲状腺相关眼病的诊断与治疗

王华丽  李险峰   

  1. 030001 太原,山西医科大学第一医院放疗科
  • 收稿日期:2014-07-30 出版日期:2015-02-22 发布日期:2015-03-03
  • 通讯作者: 李险峰,Email: lixianfeng-lxf@263.net E-mail:lixianfeng-lxf@263.net
  • 基金资助:

    山西医科大学科技创新基金资助项目(057279)

Diagnosis and treatment of active thyroid associated ophthalmopathy

WANG Hua-li, LI Xian-feng   

  1. Department of Radiation Therapy, the First Hospital of Shanxi Medical University, Taiyuan 030001, China
  • Received:2014-07-30 Online:2015-02-22 Published:2015-03-03
  • Contact: LI Xian-feng, Email: lixianfeng-lxf@263.net E-mail:lixianfeng-lxf@263.net

摘要: 甲状腺相关眼病(thyroid associated ophthalmopathy,TAO)又称Graves′眼病(Graves’ ophthalmopathy,GO),是一种器官特异的自身免疫性疾病,多数患者需经历活动期与稳定期两个阶段。临床诊断时对其活动度的判断至关重要。对于TAO,目前缺乏准确特异判断活动度的方法,如将临床活动度评分(clinical activity score,CAS)、单光子发射计算体层摄影(single photon emission computed tomography,SPECT)/CT融合图像和泪液细胞因子的测定三者有机结合,对准确判断眼部炎症活动程度、指导后期治疗方法的选择、及时控制疾病发生发展有较大帮助。对中重度活动期TAO患者的治疗三维适形球后放射治疗应作为首选,如同时联合糖皮质激素可增加疗效,并减少副反应,值得推荐。

Abstract: Thyroid\|associated ophthalmopathy (TAO) is also called Graves’ ophthalmopathy (GO). It is an organ specific autoimmune disease, most patients experience two stages:  activity and stable. Assessment of the activity of TAO is of great important for its diagnosis in clinic. In current, we still lack of an accurate and specific method to determine the activity of TAO. Combining the three methods, the clinical activity score, single photon emission computed tomography (SPECT)/CT images, and the tear cytokines, help us to measure the activity degree of eye inflammation accurately, and benefit to giving the right choice of the treatment and then controlling the disease development timely. Three dimensional conformal orbital radiotherapy is the first\|line treatment for moderate\|to\|severe TAO. And it is recommended to combined with glucocorticoids because of the increasing efficacy and reducing side effects.